| Name | Title | Contact Details |
|---|
Cyprium Partners is a private equity and mezzanine firm focused on non-controlling investments in profitable middle-market companies, allowing company owners and their management teams to retain a controlling interest in their businesses. Cyprium provides common equity, preferred stock, subordinated debt or any combination thereof, offering flexibility and increasing the certainty of close. With offices in Cleveland, New York, and Chicago, the firm invests $10 million to $60 million per transaction in U.S. and Canadian companies with $8 million or more of EBITDA.
Symphony Health Solutions provides comprehensive and multi-dimensional understanding of relevant information necessary to measure performance and inform strategies for optimal business decision-making.
VENTURE INVESTMENT ASSOCIATES (VIA) is an employee-owned manager of private equity funds of funds in venture capital, growth equity, buyouts, and energy, with total capital commitments in excess of $1 billion. Since 1993, VIA`s funds have offered its limited partners the opportunity to realize significant long-term appreciation through diversified portfolio investments in some of the most desirable private equity partnerships. In general, many of these partnerships are not available to new investors and have high minimum investment requirements. VIA`s investors include endowments, foundations, high net-worth individuals, family offices, corporations, and financial institutions. VIA`s funds are diversified across vintage years, industries and geographies, and committed to multiple managers specializing in different segments of private equity and employing varied strategies.
Veris Wealth Partners is a New York, NY-based company in the Financial Services sector.
TriplePoint Venture Growth BDC Corp. is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. It was formed to expand the venture growth stage business segment of its sponsor, TriplePoint Capital LLC. The Company’s investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by primarily lending with warrants to venture growth stage companies focused in technology, life sciences and other high growth industries backed by a select group of leading venture capital investors.